Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery.
Joey RoosenLovisa E L Westlund GotbyMark J ArntzJurgen J FüttererMarcel J R JanssenMark W KonijnenbergMeike W M van WijkChristiaan G OverduinJohannes Frank Wilhelmus NijsenPublished in: European journal of nuclear medicine and molecular imaging (2022)
Clinicaltrials.gov, identifier NCT04269499, registered on February 13, 2020 (retrospectively registered).